OUHSC Research News – Monday, March 13, 2023

 

Notices and Reminders

Proposal Submission Timeline Calculating Tool

The Office of Research Administration (ORA) is pleased to announce the addition of a new proposal submission timeline calculating tool to the Research Administration website, which principal investigators and grant administrators can use to ensure they are meeting required internal review deadlines for submitting proposals to our office.

To use this calculator, please select your proposal type (Single Project Proposal vs. Multi-Project Proposal) and enter the sponsor's submission deadline in the box to calculate the date your proposal will be due to ORA (finalized proposal documents including all required signatures). The tool also calculates the due date to ORA for an optional proposal budget review.

Please follow the link below to access the calculating tool.

https://research.ouhsc.edu/research-administration/grants/internal-deadlines

 

OUHSC Research News is intended to notify faculty and staff of new funding opportunities, upcoming workshops and seminars, agency updates, and OUHSC policies and procedures that impact sponsored research. If your department or unit has an open funding opportunity or is offering a workshop event that you would like to be included in the newsletter, you can send it to the Office of Research Administration (ORA) at oradmin@ouhsc.edu. Items for the newsletter should be received no later than 5:00 PM on Thursday to be included in the following week’s issue.   

 

Workshops and Seminars

Call for Presentations - 29th Annual Zarrow Mental Health Symposium

Description: Mental Health Association Oklahoma seeks presentation proposals from presenters around the globe interested in sharing information about treatment modalities, programs, research findings, policies and practices that are informed by science and use creative and innovative approaches to mental health. Presentations utilizing technology, innovative collaborations, new treatment and program models, and emerging knowledge and methodologies are encouraged.

Application must be submitted via the online portal found at zarrowsymposium.org, no later than Friday, April 7, 2023 to be eligible for consideration.

Questions: Please contact JoBeth Hamon at 405.898.8704 or jhamon@mhaok.org.

Additional information: Please refer to the attached flyer.

 

2023 Oklahoma Geroscience Symposium (Save the date)

Date: Monday, April 3, 2023

Time: 8:25 - 5:00 PM CST with Faculty/Trainee Mixer to Follow at 5:00 PM. Poster session 12:15 - 2:00 together with lunch.

Location: In-person 

Nicholson Tower, Floor 5, 1000 NE 13th St. Oklahoma City, OK 73104

Description: "Cell non-autonomous mechanisms of aging: Crosstalk between the periphery and the brain"

Sponsored by the Oklahoma Nathan Shock Center on Aging

Registration is free

Questions? If you have any questions regarding the symposium, please email Laura Otalora, Laura-Otalora@OUHSC.edu

Registration: https://oklahomanathanshockcenteronaging.org/symposium-registration/

Abstract Submissions: https://oklahomanathanshockcenteronaging.org/abstract-submissions/

 

2023 Oklahoma Gero-Oncology Symposium

Date: Tuesday, April 4, 2023

Time: 8:15 - 5:25 PM CST | Reception to Follow

Location: In-person & via Zoom

Nicholson Tower, Floor 5, 1000 NE 13th St. Oklahoma City, OK 73104

Description: Learn about the developments and progress happening in geriatric oncology regarding sarcopenia in aging and cancer cachexia from leading experts across the country. This symposium will feature a roundtable discussion with speakers from NCI and NIA as well as a poster session.

Full agenda coming soon.

Sponsored by OU Health Stephenson Cancer Center and the Oklahoma Nathan Shock Center on Aging

Questions? If you have any questions regarding the symposium, please email Emily Hulseberg at emily-hulseberg@ouhsc.edu.

Registration: https://oklahomanathanshockcenteronaging.org/symposium-registration/

Abstract Submissions: https://oklahomanathanshockcenteronaging.org/abstract-submissions/

 

OCRID 10th Annual Research Symposium

Date: Tuesday, April 11, 2023, 8:00 AM – 6:00 PM CDT

Location: McKnight Center for the Performing Arts, 705 West University Avenue Stillwater, OK 74074

Description: The Oklahoma Center for Respiratory and Infectious Diseases is a multi-institutional center with investigators coming from Oklahoma State University, University of Oklahoma, and the Oklahoma Medical Research Foundation.

The OCRID Annual Research Symposium provides an opportunity for researchers and students in the fields of respiratory and infectious diseases to gather, network, and learn together from a group of outstanding local and national leaders in their fields. Research disciplines include molecular biology, pathology, animal models, disease pathogenesis, therapeutics, molecular mechanisms, and bioengineering.

The one-day symposium features keynote speakers, showcases the progress of OCRID investigators’ projects and the update from OCRID core facilities, and hosts a poster competition with cash prizes. A catered breakfast, refreshment breaks, and lunch will be provided throughout the day.

Registration and additional information: Please refer to the attached flyers.

 

OUHSC Funding Opportunities

Oklahoma Nathan Shock Center on Aging (NSC) and Oklahoma Center for Therapeutic Sciences (CTS)

Genetic CRISPR Screening Pilot Award Program

 The Oklahoma Nathan Shock Center on Aging (NSC) and the Oklahoma Center for Therapeutic Sciences (CTS) are soliciting proposals for Pilot Awards in target and pathway discovery in cell-based models of aging and age-associated disease using high throughput screening and arrayed sgRNA CRISPR technologies.  Please see the attached RFA for more details.

 

The Center of Biomedical Research Excellence (COBRE) Pilot Project RFA

Description: The NIH/NIGMS-funded Oklahoma Center of Biomedical Research Excellence (COBRE) in Microbial Pathogenesis and Immunity invites proposals for pilot project awards. Pilot projects will enable investigators to generate data to support new lines of investigation funded by national level awards. The pilot project may constitute the entire basis for a new national level (NIH or NSF) funding proposal, or may extend the scope or strengthen a planned application. Pilot projects must be of high significance and enhance or generate funding proposals that will exert a high impact on the applicant’s field of research.

Eligibility Requirements: The project Principal Investigator (PI) must be a consecutive term, tenure-track, or tenured faculty member at an Institution in the State of Oklahoma. First preference will be given to junior investigators within 5 years of their initial appointment and who currently hold NIH New Investigator status. Established investigators (NIH Established Investigator, Associate Professor, and Professor) and those beyond the initial 5 year period are eligible, but the applicant must clearly demonstrate how the pilot project will add a new element or direction to the PI’s research program. The PI may not concurrently hold other COBRE or INBRE support as a full project or pilot project PI. This includes other COBRE programs in Oklahoma. Past recipients of pilot project awards will be considered for a second award contingent on priority and having fulfilled all requirements of the previous award.

Awards: The award will be $50,000 per annum in direct costs. Institutional F&A costs will also be provided for applicants at institutions outside of OUHSC. Projects may be funded for up to 2 years contingent upon fulfilling award requirements and satisfactory progress. Sub-contracts are not allowable.

Application Deadline: 5pm, March 31, 2023

Application Format and additional information: Please see the attached flyer.

 

Presbyterian Health Foundation (PHF) Bridge Grant Program – Request For Applications

• Cycle I PHF Bridge Grant Program Deadline: April 3, 2023

The primary objective of the PHF Bridge Grant Program is to provide funding to enhance OUHSC faculty competitiveness for extramural funding. OUHSC Principal Investigators are eligible if they meet the following criteria: 1) have submitted an extramural application within the past 18 months that was scored but not funded, 2) are requesting over $750,000 in total direct costs and over $200,000 in total facilities and administration (F&A) costs; and 3) received a review that ranks applications and provides critiques. 

IMPORTANT UPDATE: This program can now provide funding for up to $100,000 for one year. SALARY and FRINGE BENEFITS may be requested for the Principal Investigator(s) up to $25,000 in total (salary + fringe benefits = $25,000) with the remaining portion, $75,000, used to support the project costs. Guidelines and Application Form are attached or can be found at https://research.ouhsc.edu/research-administration/grants/funding-opportunities/phf-funding. If you have any questions, please email  VPR@ouhsc.edu.

 

American Cancer Society Institutional Research Grant (ACS IRG) – 2023 Spring Cycle

Description: The ACS-IRG is a unique source of funding entrusted to Stephenson Cancer Center (SCC) that provides seed money for early-stage faculty interested in cancer-related research - the ACS has provided SCC with supplemental monies that allow support up to two awards.  ACS-IRG funds will provide $50,000 to new/early stage faculty with Cancer Research pilot projects.

Eligibility Criteria:

• ASSISTANT PROFESSOR or equivalent level position that holds a Tenure- or Research-track appointment on OUHSC, OU-Norman or OU-Tulsa campus and within SIX years of first independent academic appointment.
• Without CURRENT grant support from national funding agencies (e.g. NIH, DOD, NSF, ACS).

Deadline: Wednesday, April 5^th, 2023, Due by 5:00 PM (CST)

Application, Guidelines and more information can be found:  Application, Forms & Guidelines | SCC Website

Questions: please contact the SCC Office of Cancer Research at CancerResearch@ouhsc.edu

 

OUHSC College of Medicine Research Fund

Description: Proposals are being accepted from full time faculty of the College of Medicine for grants to be awarded from the College of Medicine Alumni Association with proceeds generated from the Evening of Excellence dinner fund.  COMAA awards are intended to be an important resource for funding basic and clinical research projects of new and early stage investigators in the College of Medicine. The guidelines are included with this notice. Applications will be reviewed by a scientific panel whose composition will be determined on the types of applications received.  Awards generally fall within the $20,000 to $45,000 range ($45,000 maximum request). 

All applications must be routed through the Office of Research Administration and include the NIH face page (https://grants.nih.gov/grants/funding/phs398/fp1.pdf) signed by the appropriate ORA institutional official.

Below are New Guidelines for routing applications and for formatting applications for the COLLEGE OF MEDICINE ALUMNI ASSOCIATION (COMAA) research program:

1. Submission of application for review

1. At least five days prior to submission of the grant application, you must submit an electronic routing form using SOONERTRACKGRANTS (http://soonertrack.ouhsc.edu/SoonerTrackGrants.aspx). 
2. This program follows a Just-In-Time application process; therefore, approval of Institutional Review Board, Institutional Animal Care and Use Committee, Radiation Safety Committee and Institutional Biosafety Committee, where applicable, are not needed unless the application is being recommended for COMAA funding.  Applicants should only submit this information when it is requested by the Office of the Vice President for Research.  All protocols must be approved by the relevant review committees before funds are awarded.
3. The completed COMAA application must be submitted via e-mail to COMAA-Research@ouhsc.edu (cc marybeth-humphrey@ouhsc.edu) no later than 5 pm, Wednesday, April 5, 2023.  The application must be a single file in a pdf format and be titled “COMAA [PI Name]”.  Only applications that conform to the COMAA Grant Guidelines will be forwarded to the Grant Review Panel for consideration.
4. Questions about the application submission process should be addressed to Associate Dean for Research for the College of Medicine, Dr. Mary Beth Humphrey (Marybeth-humphrey@ouhsc.edu).

Please submit an electronic copy of the application along with a copy of the Completed and Approved Soonertrack Routing Form (Soonertrackgrants.ouhsc.edu).  A screenshot of the completed online PDF form will be accepted). Application must be reviewed and approved for submission by the Office of Research Administration (ORA) prior to the final application being submitted. 

The start date for funded COMAA proposals will be July 1, 2023.

Applications Due: Applications should be sent electronically to COMAA-Research@ouhsc.edu by 5 pm on Wednesday, April 5, 2023. 

Guidelines for the Submission of Proposals: Please refer to the attached application guide.

 

Call for Applications: PHF Equipment, Symposium, and Seed Grant Programs

Grant Type	Deadline
Team Science	March 24, 2023

 

 

 

Presbyterian Health Foundation (PHF) Team Science Grant Program – Request For Applications

• Cycle I PHF Team Science Grant Program Deadline: March 24, 2023

The primary objective of this PHF Team Science Grant is to foster innovative, collaborative approaches to research projects involving multiple investigators. The proposal must focus on the collaborative relationship, such that the scientific objectives could not be achieved without the efforts of at least two investigators and their respective expertise and/or disciplines. The proposal must consist of two or more investigators, with the majority at OUHSC, who can develop a broadly based, multidisciplinary research program focused on a specific disease entity, biomedical problem area, or clinically relevant problem. The combination and integration of studies may include basic, clinical, community-based and/or translational research endeavors. The proposal should focus on developing collaborative relationships and co-authored papers required for submission of multi-PI grants, program project grants, center grants, or other large collaborative-type grants (PCORI or AHRQ). The funding for this program can be for up to three years with the 2nd and 3rd year of funding, if funds are available, based on successful achievement of identified milestones, quality of specified milestones to be met during the next year of funding, and submission of a team-type grant application by the end of the 2nd year.

Each proposal submitted must consist of two or more investigators with a single investigator identified as the Contact PI/Team Leader.  The Contact PI/Team Leader must be an OUHSC primary faculty member; adjunct faculty members are not eligible. At least half of the investigators on the team must be OUHSC primary faculty members. The other investigators may be from other institutions.

 

Guidelines and Application Forms are attached or can be found at https://research.ouhsc.edu/research-administration/grants/funding-opportunities/phf-funding. If you have any questions, please email VPR@ouhsc.edu.

 

Office of Technology Commercialization presents the following opportunity for researchers to engage with industry (click here for more information, or email otc@ou.edu or gina-mcmillen@ouhsc.edu).  

• Ipsen, a global biopharmaceutical company, is seeking novel and innovative leads to treat rare diseases and rare neuroscience disease indications. A range of therapeutic areas, targets, and mechanisms-of-action and classes of molecules are of interest, with a specific focus on small molecule, peptide, biologics, nucleic acids, RNA therapies and antibody conjugates.   Out of scope are gene therapy, cell therapy, vaccines, generics and natural products.  Submission entails a 1-pg non-confidential proposal form, including workplan and budgetary requirements.  (deadline 4/12).

 

Investigator Initiated Trials Funding Committee (IITFC), Clinical Trials Office-Protocol Support Unit Description: Grant proposals are being accepted for the 2023 Spring cycle from Stephenson Cancer Center Providers for their investigator-initiated clinical trials (IITs) or translational work for the amount of up to $100,000 for clinical trials, and up to $25,000 for translation research. All applications should be submitted to the Protocol Support Unit at SCC-IIT-Office@ouhsc.edu and should adhere to the Grant template and Submission Checklist provided with this notice. Investigators should request the budget template from the Protocol Support Unit.

Deadline: April 3, 2023 at 5 pm CST

Link to the full announcement or a flier: Please refer to the attached flyer for additional funding criteria and details

 

NIH Notices 

• Notice of Availability of Frequently Asked Questions (FAQs) for RFA-HL-24-003, RFA-HL-24-004, and NOT-HL-22-039 "Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE)"
  (NOT-HL-23-081)
• Notice of Information: NCATS Prior Approval Process for New CTSA Program UM1 and K12 Scholar Projects that Involve Human Subjects Research
  (NOT-TR-23-007)
• Notice of Information of Fogarty International Center's Participation in the Notice of Special Interest: Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars
  (NOT-TW-23-003)
• Notice of Information of Fogarty International Center's Participation in the Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards
  (NOT-TW-23-004)
• Notice of Participation of the National Institute on Aging (NIA) in RFA-ES-23-007 "Exploratory Grants for Climate Change and Health Research Center Development (P20 Clinical Trial Optional)"
  (NOT-AG-23-013)
• Notice of Change to the Funding Opportunity Description of RFA-ES-23-004, "Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed)"
  (NOT-ES-23-008)
• Notice to Extend the Application Due Date for RFA-FD-23-020 - Cooperative Agreement to Support the Food and Agriculture Organization (FAO) (U01) Clinical Trials Not Allowed
  (NOT-FD-23-008)
• Notice of Change to Funding Opportunity AHRQ Improving Diagnostic Safety in Ambulatory Care: Strategies and Preventions
  (NOT-HS-23-009)
• Notice of Intent to Publish a Funding Opportunity Announcement for HIV Prevention and Alcohol (R01 Clinical Trials Optional)
  (NOT-AA-23-005)
• Notice of Intent to Publish a Funding Opportunity Announcement for HIV Prevention and Alcohol (R34 Clinical Trials Optional)
  (NOT-AA-23-006)
• Notice of Intent to Publish a Funding Opportunity Announcement for The Blood and Marrow Transplant Clinical Trials Network - Core Clinical Centers (UG1)
  (NOT-HL-23-068)
• Notice of Intent to Publish a Funding Opportunity Announcement for The Blood and Marrow Transplant Clinical Trials Network - Data Coordinating Center (U24)
  (NOT-HL-23-069)
• Notice of Special Interest: Advancing mHealth Interventions for Understanding and Preventing Alcohol-Related Domestic Violence
  (NOT-AA-23-003)
• Notice of Special Interest (NOSI): NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19)
  (NOT-DE-23-004)
• Notice of Special Interest (NOSI): Availability of Administrative Supplements to Advance the Use of Electronic Health Records for Research
  (NOT-GM-23-035)
• Notice of Special Interest (NOSI): Climate Change and Health Administrative Supplements
  (NOT-HD-23-006)
• Notice of Special Interest (NOSI): Integrative Omics Analysis of NHLBI TOPMed Data (Parent R01 Clinical Trial Not Allowed)
  (NOT-HL-23-067)
• Notice of Special Interest (NOSI): Research Project Grants in Valvular Heart Disease (CAROL Act)
  (NOT-HL-23-079)
• Notice of Special Interest (NOSI): Administrative Supplements to Enhance Software Tools for Open Science
  (NOT-OD-23-073)
• Notice of Special Interest (NOSI): Administrative Supplements to Support Collaborations to Improve the AI/ML-Readiness of NIH-Supported Data
  (NOT-OD-23-082)
• Notice of Special Interest (NOSI): Administrative Supplement for Research Efforts that Elucidate Fundamental Processes Underlying Behavior Change, Maintenance, and Adherence (Admin Supp Clinical Trial Optional)
  (NOT-OD-23-083)
• Notice of Special Interest: Administrative Supplements to NIH-funded T32 and TL1 Training Grants to Better Integrate Behavioral and Social Sciences (BSS) with other Health-Related Sciences
  (NOT-OD-23-098)
   

 

NIH Funding Opportunities

• NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed)
  (PAR-23-109)
  Application Receipt Date(s): August 08, 2025
• Biomedical Technology Optimization and Dissemination Center (BTOD)(RM1-Clinical Trial Not Allowed)
  (PAR-23-110)
  Application Receipt Date(s): Multiple dates, see announcement.
• Centers for AIDS Research (P30 Clinical Trial Not Allowed)
  (PAR-23-116)
  Application Receipt Date(s): Not Applicable
• Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)
  (PAR-23-117)
  Application Receipt Date(s): Not Applicable
• National Centers for Cryoelectron Microscopy (R24 Clinical Trial Not Allowed)
  (PAR-23-118)
  Application Receipt Date(s): June 28, 2024
• Diagnostic Centers of Excellence (X01 Clinical Trial Not Allowed)
  (PAR-23-120)
  Application Receipt Date(s): Multiple dates, see announcement.
• Avenir Award Program for Research on Substance Use Disorders and HIV (DP2 Clinical Trial Optional)
  (PAR-23-125)
  Application Receipt Date(s): Not Applicable
• Coordination Center for the Models of Infectious Disease Agent Study (MIDAS) Program (R24 Clinical Trial Not Allowed)
  (PAR-23-129)
  Application Receipt Date(s): June 15, 2023
• Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)
  (PAS-23-086)
  Application Receipt Date(s): Multiple dates, see announcement.
• Addressing the Primary Care Needs of Cancer Survivors (U01 Clinical Trial Required)
  (RFA-CA-23-025)
  Application Receipt Date(s): June 30, 2023
• SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed)
  (RFA-ES-23-005)
  Application Receipt Date(s): July 14, 2023
• FDA OMHHE Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed
  (RFA-FD-23-011)
  Application Receipt Date(s): May 08, 2023
• Population Dynamics Centers Research Infrastructure Program FY 2024 (P2C Clinical Trial Not Allowed)
  (RFA-HD-24-008)
  Application Receipt Date(s): July 28, 2023
• Understanding Chronic Conditions Understudied Among Women (R21 Clinical Trial Optional)
  (RFA-OD-23-013)
  Application Receipt Date(s): June 20, 2024
• Understanding Chronic Conditions Understudied Among Women (R01 Clinical Trial Optional)
  (RFA-OD-23-014)
  Application Receipt Date(s): June 20, 2024

 

Other Funding Opportunities

HRSA Nurse Education, Practice, Quality and Retention (NEPQR)-Pathway to Registered Nurse Program (PRNP) (HRSA-23-016)

Description: The Health Resources and Services Administration (HRSA) released a new Notice of Funding Opportunity (NOFO). The Nurse Education, Practice, Quality and Retention (NEPQR) - Pathway to Registered Nurse Program (PRNP) aims to create a pathway from academic training to clinical practice through the creation and implementation of Licensed Practical Nurse/Licensed Vocational Nurse (LPN/LVN) to Registered Nurse (RN) Bridge Programs and employment of Clinical Nurse Faculty.

HRSA will award approximately $8.9 million to up to 8 cooperative agreements over a period of four years.

Application Deadline: April 27, 2023

Link to Full Announcement: https://www.hrsa.gov/grants/find-funding/HRSA-23-016?UTM_campaign=NOFO

 

DoD Ovarian Cancer Research Program (OCRP)

• Investigator-Initiated Research Award (IIRA)
• Ovarian Cancer Academy Award - Early-Career Investigator (OCA)
• Pilot Award (PA)

Pre-Application: April 17, 2023

Application: July 21, 2023

Link to Full Announcement: https://cdmrp.health.mil/funding/ocrp

 

The Leona M. and Harry B. Helmsley Charitable Trust- Request for Applications to advance collaborative research in T1D prevention

Description: This RFP supported in collaboration with JDRF Australia, seeks collaborative projects to help answer unknowns about T1D biological mechanisms, with studies on its samples and data collected from pregnancy through childhood from children with an immediate family member with T1D.

LOI Deadline: April 7, 2023

Link to Full Announcement: https://jdrf.org.au/for-researchers/type-1-diabetes-prevention-rfa/

 

HRSA Advanced Nursing Education Workforce (ANEW) Program (HRSA-23-014)

Description: The Health Resources and Services Administration (HRSA) released a new Notice of Funding Opportunity (NOFO). The Advanced Nursing Education Workforce (ANEW) Program aims to increase the number of primary care nurse practitioners, clinical nurse specialists, and certified nurse midwives trained and prepared to provide primary care services, mental health and substance use disorder care, and maternal health care. The grants will support the training and graduation of advanced practice registered nursing (APRN) students and trainees in these disciplines.

Application Deadline: April 7, 2023

Link to Full Announcement: https://www.hrsa.gov/grants/find-funding/HRSA-23-014?UTM_campaign=Funding+Announcement+-+Advanced+Nursing+Education+Workforce

 

HRSA Advanced Nursing Education Nurse Practitioner Residency and Fellowship (ANE-NPRF) Program (HRSA-23-009)

Description: The Health Resources and Services Administration (HRSA) released a new Notice of Funding Opportunity (NOFO) for the Advanced Nursing Education Nurse Practitioner Residency and Fellowship (ANE-NPRF) Program, which aims to prepare new Advanced Practice Registered Nurses (APRNs) to effectively provide primary care by supporting transition to practice through the expansion and/or enhancement of existing Nurse Practitioner (NP) residency programs. The program also focuses on the integration of behavioral health and maternal health into primary care by training new primary care providers, behavioral health providers, and certified nurse midwives in community-based settings.

HRSA will award approximately $30 million to up to 43 grantees over a period of four years.

Application Deadline: April 11, 2023

Link to Full Announcement: https://www.hrsa.gov/grants/find-funding/HRSA-23-009?UTM_campaign=NOFO+Announcement+-+ANE+NPRF+Program  

 

DoD Amyotrophic Lateral Sclerosis Research Program (ALSRP)

• FY23 ALSRP Clinical Biomarker Development Award Program Announcement
• FY23 ALSRP Pilot Clinical Trial Award Program Announcement
• FY23 ALSRP Therapeutic Development Award Program Announcement
• FY23 ALSRP Therapeutic Idea Award Program Announcement

Pre-Application: 4-13-2023

Application: 7-13-2023

Link to Full Announcement: https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=495104

 

DoD Breast Cancer Research Program (BCRP)

• FY23 BCRP Breakthrough Award Funding Levels 1 and 2 Program Announcement

Pre-Application (Letter of Intent): 3-28-2023

Application: 4-11-2023

• FY23 BCRP Breakthrough Award Level 3 Program Announcement

Pre-Application (Letter of Intent): 3-29-2023

Application: 6-28-2023

• FY23 BCRP Breakthrough Award Level 4 Program Announcement

Pre-Application (Letter of Intent): 3-29-2023

Application: 6-28-2023

• FY23 BCRP Clinical Research Extension Award Program Announcement

Pre-Application (Letter of Intent): 3-28-2023

Application: 4-11-2023

• FY23 BCRP Era of Hope Scholar Award Program Announcement

Pre-Application (Letter of Intent): 3-28-2023

Application: 4-11-2023

• FY23 BCRP Innovator Award Program Announcement

Pre-Application (Letter of Intent): 3-29-2023

Application: 6-28-2023

• FY23 BCRP Transformative Breast Cancer Consortium Award Program Announcement

Pre-Application (Letter of Intent): 3-29-2023

Application: 6-28-2023

• FY23 BCRP Transformative Breast Cancer Consortium Development Award Program Announcement

Pre-Application (Letter of Intent): 3-28-2023

Application: 4-11-2023

Link to Full Announcement: https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=495102

 

DoD Epilepsy Research Program (ERP)

• FY23 ERP Idea Development Award Program Announcement
• FY23 ERP Leveraging Research Award Program Announcement
• FY23 ERP Research Partnership Award Program Announcement
• FY23 ERP Virtual Post-Traumatic Epilepsy Research Center Faculty Award Program Announcement

Pre-Application (Letter of Intent): 5-19-2023

Application: 6-23-2023

Link to Full Announcement: https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=495101

 

DoD Peer Reviewed Medical Research Program (PRMRP)

• FY23 PRMRP Clinical Trial Award Program Announcement

Pre-Application (Letter of Intent): 4-12-2023

Application: 7-19-2023 

• FY23 PRMRP Discovery Award Program Announcement

Pre-Application (Letter of Intent): 3-29-202

Application: 4-26-2023

• FY23 PRMRP Focused Program Award

Pre-Application (Letter of Intent): 4-12-2023

Application: 7-19-2023 

• FY23 PRMRP Investigator-Initiated Research Award Program Announcement

Pre-Application (Letter of Intent): 4-19-2023

Application: 5-31-2023

• FY23 PRMRP Lifestyle and Behavioral Health Interventions Research Award Program Announcement

Pre-Application (Letter of Intent): 4-19-2023

Application: 5-31-2023

• FY23 PRMRP Technology/Therapeutic Development Award Program Announcement

Pre-Application (Letter of Intent): 4-19-2023

Application: 5-31-2023

Link to Full Announcement: https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=495103

 

The International Center for Responsible Gaming - REQUEST FOR APPLICATIONS ON RESEARCH ON PRE-COMMITMENT AS A PREVENTION MEASURE TO REDUCE GAMBLING-RELATED HARMS

Description: The International Center for Responsible Gaming (ICRG) invites investigators to apply for a two-year Large Grant to study the effectiveness of “pre-commitment,” a prevention strategy that encourages gamblers to set limits on money and time spent gambling. Applicants may request up to a total of $75,000 per year for up to two years plus 15 percent in Facilities & Administration costs. Total amount that may be requested is $172,500.

Application Deadline: May 15, 2023

Link to Full Announcement: https://www.icrg.org/information/apply-for-icrg-funding

 

Cystic Fibrosis Foundation Multiple Principal Investigator Clinical Award

Description: The Multiple Principal Investigator (MPI) Clinical Award provides support for multi-investigator-initiated clinical research projects that have the potential to make an important contribution to the CF Foundation’s mission. Research projects may be designed to address a range of research areas, from clinical pilot and feasibility work to clinical (observational/interventional), translational or epidemiologic study approaches. Each investigator is expected to be a significant contributor to the project and share the responsibility and authority for leading and directing the project. Collaborations that bring new investigators and technologies into the CF research community will be given highest priority. Please note that applicants must speak with program staff prior to submission of an LOI. For questions, please contact Dara Riva (driva@cff.org). 

Letter of Intent Due: March 22, 2023

Link to Full Announcement: https://www.cff.org/researchers/multiple-principal-investigator-clinical-award

 

Cystic Fibrosis Foundation Health Equity Team Science Award

Description: The Health Equity Team Science Award RFA will help address key research questions related to health disparities and to improve health equity within the CF Community. The RFA aims to fund cross-disciplinary teams that may propose up to three related research projects (each led by a separate principal investigator) that share a well-defined theme and overall objective. We are holding a webinar on February 28, 2023 from 1-2pm ET to review RFA content and the submission process, and will allow time for Q&A. Please note that applicants must speak with program staff prior to submission of an application. For questions, please contact Dara Riva (driva@cff.org).  

Letter of Intent Due: March 29, 2023

Link to Full Announcement: https://www.cff.org/researchers/health-equity-team-science-award